Evidence map›Paper›PMID 37872265›Full record

ArticleScientific reports2023

The molecular epidemiology of SARS-CoV-2 in the Pityusic Islands shows multiple introductions and fast replacements of variants in a touristic worldwide hot spot.

T Viver, C López-Causapé, P Ribot-Fraile, C Pérez-Mazón, D López-Solé, G Jiménez-Guerra, B Taltavull, A López-López

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

T ViverMarine Microbiology Group, Mediterranean Institute for Advanced Studies (IMEDEA-CSIC-UIB), Esporles, Spain.
C López-CausapéServicio de Microbiología, Hospital Universitario Son Espases, Majorca, Illes Balears, Spain.
P Ribot-FraileServicio de Microbiología, Hospital Universitario Son Espases, Majorca, Illes Balears, Spain.
C Pérez-MazónServicio de Microbiologíaa y Parasitología, Hospital Can Misses, C/ Corona s/n, 07800, Ibiza, Illes Balears, Spain.
D López-SoléServicio de Microbiologíaa y Parasitología, Hospital Can Misses, C/ Corona s/n, 07800, Ibiza, Illes Balears, Spain.
G Jiménez-GuerraServicio de Microbiologíaa y Parasitología, Hospital Can Misses, C/ Corona s/n, 07800, Ibiza, Illes Balears, Spain.
B TaltavullInstituto de Investigación Sanitaria Illes Balears (IdISBa), Majorca, Illes Balears, Spain.
A López-LópezServicio de Microbiologíaa y Parasitología, Hospital Can Misses, C/ Corona s/n, 07800, Ibiza, Illes Balears, Spain. aranzazu.lopezlopez@asef.es.
Hospital Can Misses · ESHealth Research Institute of the Balearic Islands · ESMediterranean Institute for Advanced Studies · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The public health emergency caused by the Covid-19 outbreak in March 2020 encouraged worldwide initiatives to monitor the genetic diversity and features of the SARS-CoV-2 circulating variants, mainly based on the genomic surveillance. However, due to the impossibility to carry out extensive sequencing in resource-limited hospitals, other PCR-based strategies could be applied to efficiently monitor the circulating variants without the need to greatly expand the sequencing capacity. In our case, overpassing the technical limitations inherent to a second level hospital, we were able to characterize the weekly distribution of SARS-CoV-2 by the RT-qPCR amplification patterns visualization, single nucleotide polymorphism genotyping, and sequencing of randomly selected samples. All these molecular approaches allowed us to trace the epidemiology of SARS-CoV-2 viruses circulating in Ibiza and Formentera (Balearic Islands, Spain) during the third to the sixth pandemic waves (January 2021-July 2022), in which three major lineages that were considered as VOCs (Alpha, Delta, and Omicron), and many other non-VOC variants were detected and tracked.

Indexed as

COVID-19DermatitisBase SequenceHumansMolecular EpidemiologySARS-CoV-2

Identifiers

PMID37872265
PMCPMC10593736
OpenAlexW4387879084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.